Key Insights

Highlights

Treatment Research

2 treatments under study, led by Myriad Applied In Conjunction With Npwt

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Myriad Applied In Conjunction With Npwt1
  • Npwt Alone1

Active Sponsors

  • Coalition for National Trauma Research1
  • Aroa Biosurgery Limited1

Top Investigators

Related Conditions

  • Soft Tissue Defects1
  • Soft Tissue Wounds1

Activity Timeline